CIK 0001559053
- Accelerated filer
PROTHENA CORP PUBLIC LTD CO
Sign in to watch- Ticker
- PRTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +353 12362500
- Business address
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
- Former names
- Prothena Corp plc, Neotope Corp Ltd
- Open-market buys, last 90 days
- $9,848,721
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,848,721. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-23 | Malecek Michael J Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +85,000 | 85,000 | ||
| 2022-01-12 | EcoR1 Capital, LLC 10% owner | Purchase | +300,000 | $37.50 | $11.3M | 11,584,280 |
| 2022-01-03 | Selkoe Dennis J. Director | Option exercise | +5,000 | $9.23 | $46K | 7,845 |
| 2022-01-03 | Selkoe Dennis J. Director | Sale | −2,133 | $46.81 | $100K | 5,712 |
| 2022-01-03 | Selkoe Dennis J. Director | Sale | −2,375 | $47.60 | $113K | 3,337 |
| 2022-01-03 | Selkoe Dennis J. Director | Sale | −492 | $49.48 | $24K | 2,845 |
| 2022-01-03 | Selkoe Dennis J. Director | Option exercise · Stock Option (Right to Buy) | +5,000 | 6,000 | ||
| 2021-11-23 | Walker Karin L Chief Accounting Officer | Option exercise | +4,519 | $15.04 | $68K | 4,519 |
| 2021-11-23 | Walker Karin L Chief Accounting Officer | Sale | −2,700 | $57.51 | $155K | 1,819 |
| 2021-11-23 | Walker Karin L Chief Accounting Officer | Sale | −1,819 | $58.43 | $106K | 0 |
| 2021-11-23 | Walker Karin L Chief Accounting Officer | Option exercise · Stock Option (right to buy) | −4,519 | 85,481 | ||
| 2021-11-19 | Malecek Michael J See Remarks | Option exercise | +10,000 | $10.27 | $103K | 10,000 |
| 2021-11-19 | Malecek Michael J See Remarks | Sale | −10,000 | $55.00 | $550K | 0 |
| 2021-11-19 | Malecek Michael J See Remarks | Option exercise · Stock Option (Right to Buy) | −10,000 | 230,000 | ||
| 2021-11-01 | Karp Carol D. Chief Regulatory Officer | Option exercise | +10,000 | $15.04 | $150K | 10,000 |
| 2021-11-01 | Karp Carol D. Chief Regulatory Officer | Sale | −2,338 | $55.00 | $129K | 7,662 |
| 2021-11-01 | Karp Carol D. Chief Regulatory Officer | Sale | −2,725 | $56.65 | $154K | 4,937 |
| 2021-11-01 | Karp Carol D. Chief Regulatory Officer | Sale | −4,937 | $58.51 | $289K | 0 |
| 2021-11-01 | Karp Carol D. Chief Regulatory Officer | Option exercise · Stock Option (Right to Buy) | −10,000 | 120,000 | ||
| 2021-10-27 | Malecek Michael J See Remarks | Option exercise | +10,000 | $10.27 | $103K | 10,000 |
Page 29 of 41 · 819 trades